Constance Cirrincione

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results From CALGB 40603 (Alliance)”.

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results From CALGB 40603 (Alliance)

UNC Libraries(2020)10.17615/gk9w-nn28

N/A

0DataRank · unranked

24 citations

Mehra Golshan, David W. Ollila, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer +5 more

Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2020)10.17615/pdfa-n953

N/A

0DataRank · unranked

0 citations

Thomas J. FitzGerald, William P. Peters, F. Laurie, Steven L. Seagren, Jinli Ma +13 more

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

UNC Libraries(2020)10.17615/8he8-0367

N/A

0DataRank · unranked

0 citations

Stuart M. Lichtman, Aminah Jatoi, Arti Hurria, Constance Cirrincione, Antonio C. Wolff +6 more

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

UNC Libraries(2020)10.17615/3qn5-sn85

N/A

0DataRank · unranked

0 citations

Lisa A. Carey, Beth Overmoyer, Constance Cirrincione, William M. Sikov, Mehra Golshan +9 more

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

UNC Libraries(2020)10.17615/6adk-r027

N/A

0DataRank · unranked

0 citations

Carey K. Anders, Charles M. Perou, Ian E. Krop, Constance Cirrincione, Brandelyn N. Pitcher +13 more

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

The Lancet(2023)10.1016/s0140-6736(23)00285-4

N/A

0DataRank · unranked

195 citations

Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető +95 more